Ryan Braun Defending Himself from drug Allegations

.

Ryan Braun Defending Himself from drug Allegations

After being banned to play in 50 matches, Ryan Braun launched an attack over the system saying that he the system of flawed.

In October, Ryan Braun was tested for drugs which turned out to be positive. The player was alleged of consuming drugs and thus was banned to play the coming 50 matches. However, Thursday, the aggrieved player at Maryvale Park launched an attack over the system and defended himself saying that the system which alleged him of using drug is flawed.

While commenting upon the horrifying incident taking place in his career life, Braun said, “I've tried to handle the entire situation with honor, with integrity, with class, with dignity and with professionalism…If I had done this…I'd be the first one to step up and say I did it”.

Braun said that when the tests were being conducted something went out on a limb with the samples collected by the authorities concerned. However, when asked as to why his blood samples showed a testosterone-to-epitestosterone ratio of 20-to-1, he didn’t have any answer to it.

The points raised by the Braun have put the authorities in to the tight position. Braun didn’t allege anyone directly. He simply said that something went wrong with his samples. The remarks made by Braun has raised several questions related to as to what made him say so, is there anyone who might have played game with Braun and are the tests right.

It has been reported that further tests would be conducted to make sure that Braun is being punished for the violation. If his tests reveal that he has not been using drugs then he would be saved from the penalties of
50 matches. Further tests over him would be conducted soon.


Latest News

Rise in Russian Arms Sales In spite of a Drop Globally
PetSmart Sells itself with an $8.3Billion Deal
Falling Oil Prices Result in a Drop in Stocks
Shares of Amaya Fall Due to Probe Conducted by Securities Regulators
Americans Consumers Display Confidence In the Market with Gain in Sales
It’s Time to Hurry Up to Enrol in the First Phase of Affordable Care Act Health
After Merger with Alliance Boots,	Walgreen CEO will Retire
Falling Fuel Prices Lift Airline Profits But No Respite in Fares Expected
Citigroup to Pay Likely $2.7B as Legal Charge
Michael Jeffries Retires as the CEO of Abercrombie & Fitch
Deutsche Bank in Trouble Again in the U.S. for Alleged Tax Scheme
Popular Demand Brings French Toast Crunch Back on the Shelves